Article
Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.
Breast cancer research and treatment - 1 Dec 2011
Vuorela Mikko, Pylkäs Katri, Hartikainen Jaana M, Sundfeldt Karin, Lindblom Annika, von Wachenfeldt Wäppling Anna, Haanpää Maria, Puistola Ulla, Rosengren Annika, Anttila Maarit, Kosma Veli-Matti, Mannermaa Arto, Winqvist Robert
Abstract excerpt
RAD51C, a RAD51 paralogue involved in homologous recombination, is a recently established Fanconi anemia and breast cancer predisposing factor. In the initial report, RAD51C mutations were shown to confer a high risk for both breast and ovarian tumors, but most of the replication studies published so far have failed to identify any additional susceptibility alleles. Here, we report a full mutation screening of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
